Stay updated on Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH operations was added, and the page version updated from v3.4.0 to v3.4.1, with no modifications to the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:55:48.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    UI text updates include a Show glossary label, the Last Update Submitted that Met QC Criteria entry, the No FEAR Act Data indicator, and the Revision: v3.4.0 note. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:21:15.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision entry updated from v3.3.3 to v3.3.4, adding the new version label and removing the previous one.
    Difference
    0.1%
    Check dated 2026-01-14T02:47:00.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page now includes a dedicated Locations section with Maryland listed as a site, and it notes Revision: v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:35:03.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0. This appears to be a backend/versioning update and does not change study content.
    Difference
    0.1%
    Check dated 2025-11-24T17:54:51.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    - Removed a site-wide notice about a lapse in government funding and NIH operating status. The study record details (title, conditions, interventions, outcomes) remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T17:51:57.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.